Extraction of semi-volatile organic compounds in drinking water with Atlantic® ReadyDisk

By Biotage

Introduction


Drinking water is one of the primary sources of human exposure to toxic chemicals. The U.S. EPA identifies and regulates a number of compounds in drinking water that could pose health risks, and outlines methods for properly quantifying them.

Contaminants can be biological, physical, chemical or radiological, and can exist in a wide range of concentrations. Therefore, the list of EPA methods that are approved for use in testing drinking water is extensive and each method presents its own challenges, based on the specific compounds being quantified.

EPA Method 525.2 is used to quantitate organic compounds found in drinking and source waters. Method 525.2 uses a reversed phase separation mechanism to isolate a large variety of compounds from the sample matrix. The reversed phase separation is achieved using a C18 bonded silica stationary phase which is packed into an SPE cartridge or disk. The C18 stationary phase allows for the extraction of semi-volatile compounds from the sample matrix which are then analysed by gas chromatography-mass spectrometry (GC-MS).1


Instrumentation


All samples were analysed using the instrumentation listed in Table 1 below.

Table 1: Instrumentation

Sample Preparation

Solid Phase Extraction Disk

Atlantic® ReadyDisk HC-C18

Extraction System

Biotage® Horizon 5000

Drying/Concentration System

Biotage® Horizon DryVap® with DryDisk® Separation Membranes

Analysis

GC/MS Instrument             

Agilent 6890 with 5975C Inert GC/MSD

*The DryVap™ system has been discontinued. We recommend using the TurboVap® evaporation systems for achieving equivalent results.

Experimental


The organic compounds were eluted from the ReadyDisk with small quantities of ethyl acetate, followed by methylene chloride, followed by a 1 to 1 (v/v) mixture of ethyl acetate to methylene chloride. The extracted solution was dried and concentrated via solvent evaporation using the DryVap™* with DryDisk® Separation Membranes.
The sample components were separated, identified, and measured using the gas chromatography/mass spectrometry (GC/MS) system listed in Table 1.


A summary of the overall sample preparation, extraction, drying and concentration procedure is listed below. A detailed overview of the method that was run on the Biotage® Horizon 5000 is listed in Table 2. The DryVap™ and Agilent GC/MS parameters are listed in Table 3 and 4, respectively.

  1.  Obtain 1-liter samples of drinking water.
  2.  Add dechlorinating agent to each 1-liter sample.
  3. Acidify each sample to pH <2 using concentrated HCl.
  4.  Add surrogate and internal standard compounds to each sample.
  5. Start extraction method shown in Table 2 and collect all extracts (~20 mL each).
  6. Add each extract to the DryDisk® holder and start automated drying and concentration process on the DryVap™ system. Evaporate each extract to 0.9 mL using the method listed in Table 3.
  7. Quantitatively, bring each extract volume to 1.0 mL using ethyl acetate.
  8. Add external standard to each extract.
  9. Transfer the extract to a 2.0 mL GC vial.

 

Table 2: Extraction method

 Step

Solvent Volume (mL)

Purge Time (s)

Pump Rate (#)

Saturation Time (s)

Soak Time (s)

Drain Time (s)

1. Condition SPE Disk            Ethyl Acetate

20

60

2

1

0

45

2. Condition SPE Disk                Methylene Chloride

20

60

2

1

0

45

3. Condition SPE Disk                Methanol

20

60

2

2

60

10

4. Condition SPE Disk                 Reagent Water

20

30

2

1

60

10

 

Step

Sample Flow Rate (#)

Done Loading Sample Delay (s)

5. Load Sample

2 (approximately 70 mL/min)

45

Step

Dry Time (s)

Pump Speed (#)

N2 Blanket

6. Air Dry Disk Timer

600

6

OFF

Step

Solvent

Solvent Volume (mL)

Purge Time (s)

Pump Rate(#)

N2

Blanket

Saturation Time (s)

Soak Time (s)

Drain Time (s)

7. Elute Sample Container

Ethyl Acetate

5

60

2

Off

1

60

45

8. Elute Sample Container

Methylene Chloride

5

60

2

Off

1

60

45

9. Elute Sample Container

1:1 EtOAc/MeCl

5

15

2

Off

1

60

45

10. Elute Sample Container

1:1 EtOAc/MeCl

5

15

6

Off

1

60

60

Table 3: drying and concentration process

Parameters

Value

Drying Mechanism

DryDisk® (PN: 40-705-HT)

Dry Volume

100 mL

Heater Power

5

Heater Timer

Off (automatic endpoint mode used)

Auto Rinse

Off

Table 4: Agilent GC/MS parameters

Parameter

Value

Injection Volume

1 µL

Inlet Temperature

280 °C

Mode

Splitless

Gas Type

Helium

Cartridge Conditions

ZB-SemiVol (Phenomenex), 30 m, 0.25 mm, 0.25 µm

Mode

Constant Flow 1 mL/min

Oven Program

60 °C hold for 2 minutes

Ramp 20 °C/min to 270 °C

Ramp 6 °C/min to 320 °C

Hold for 3 minutes

 

Results and discussion


Per EPA Method 525.2, a series of laboratory reagent blanks (LRBs) were measured to demonstrate a lack of contamination from the extraction system and the Atlantic® ReadyDisk HC-C18, prior to analysing any samples. Six replicate LRBs were prepared and extracted as described in EPA Method 525.2, following the procedure in the method summary in this note. All blanks were spiked with internal standards such that their final concentration in solution was 5 µg/L. The results for the six LRBs are shown in Table 5 below.

To demonstrate an Initial Demonstration of Laboratory Accuracy and Precision (IDA and IDP), six replicates of a laboratory fortified blank (LFB) were prepared and extracted as described in EPA Method 525.2. Each replicate contained all analytes of interest, including internal standards and surrogates, at 5 µg/L. For each measured analyte and surrogate, the mean accuracy, expressed as a percentage of the true value, should be 70-130 % and the RSD should be less than 30 %, per Method 525.2.1 Results for the six samples are shown in Table 5 below.

Seven additional laboratory fortified blanks were prepared such that all analytes of interest were present at approximately 0.5 µg/L. All seven replicates were analysed on three consecutive days to produce data for calculating method detection limits (MDLs).

Method Detection Limits (MDLs) were calculated based on the measured LFB solutions and are reported in Table 5 below. Results are based on the standard deviation of the replicate measurements, multiplied by the appropriate Student’s t value for the 99 % confidence interval. Results are reported Not Detected (ND) if the measured concentration for all samples were below the lowest calibration point of 0.1 µg/L.


The method detection limits (MDL) were calculated using the formula1:
MDL = S x t (n-1, 1 α 0.99)

Where:
t = Student’s t value for the 99% confidence level (n-1,1-α = 0.99) with n-1 degrees of freedom
n = number of replicates
S = standard deviation of replicate analyses

Table 5: Method detection limits

Analyte

Average Recovery (%) n=6

RSD (%) n=6

MDL (μg/L)

n=7

Blank (μg/L)

n=6

Acenaphthene d10

78.8

4.44

-

4.06

Phenanthrene d10

82.2

4.44

-

4.31

Chrysene d12

79.3

8.09

-

3.94

Isophorone

106.3

1.96

0.04

ND

2-Nitro-m-xylene

90.2

3.91

0.09

ND

Naphthalene

78.9

8.42

0.09

ND

Dichlorvos

109.1

1.71

0.07

ND

Hexachlorocyclopentadiene

27.6

23.07

ND

ND

EPTC

105.8

1.70

0.04

ND

Mevinphos

111.5

1.09

0.10

ND

Butylate

101.0

2.18

0.05

ND

Vernolate

105.9

1.47

0.05

ND

Dimethyl phthalate

113.5

1.91

0.06

ND

Pebulate

105.5

1.51

0.04

ND

Etridiazole

97.1

2.38

0.07

ND

2,6-Dinitrotoluene

110.6

1.41

0.08

ND

Acenaphthylene

98.9

2.10

0.05

ND

Acenaphthene

109.0

2.51

0.06

ND

Chloroneb

111.5

2.00

0.10

ND

Tebuthiuron

101.4

1.68

0.10

ND

2,4-Dinitrotoluene

106.5

1.42

0.05

ND

Molinate

108.6

1.63

0.05

ND

Diethyl phthalate

114.7

1.83

0.21

0.04

Fluorene

104.1

1.30

0.06

ND

Propachlor

111.9

1.50

0.09

ND

Ethoprop

110.2

1.55

0.08

ND

Cycloate

110.5

1.59

0.05

ND

Chlorpropham

113.4

1.73

0.09

ND

Trifluralin

101.7

5.10

0.08

ND

a-BHC

110.7

1.46

0.05

ND

Atraton

25.3

28.64

ND

ND

Hexachlorobenzene

96.9

6.67

0.08

ND

Dimethoate

80.0

11.81

0.09

ND

Prometon

37.6

19.63

ND

ND

Lindane (g-BHC)

110.4

1.39

0.06

ND

Simazine

104.9

1.23

0.05

ND

Atrazine

104.7

1.82

0.07

ND

Propazine

108.3

1.18

0.04

ND

b-BHC

110.6

1.38

0.04

ND

Pentachlorophenol

98.2

2.04

0.04

ND

Terbuthylazine

104.9

2.31

0.04

ND

Terbufos

91.0

6.94

0.03

ND

Pronamide

106.3

1.36

0.03

ND

Diazinon

95.7

1.77

0.07

ND

d-BHC

107.8

1.81

0.02

ND

Phenanthrene

105.0

1.62

0.03

ND

Disulfoton

82.4

8.00

0.06

0.12

Methyl paraoxon

107.1

0.88

0.16

ND

Anthracene

78.4

11.40

0.07

ND

Terbacil

97.6

4.56

0.10

0.37

Chlorothalonil

109.8

2.99

0.05

ND

Caffeine

85.9

10.85

0.07

ND

Analyte

Average Recovery (%) n=6

RSD (%) n=6

MDL (μg/L)

n=7

Blank (μg/L)

n=6

Acetochlor

103.3

2.39

0.07

ND

Metribuzin

110.6

1.62

0.08

ND

Simetryn

79.0

13.56

0.17

ND

Heptachlor

96.3

5.80

0.08

ND

Ametryn

89.5

9.39

0.20

ND

Alachlor

105.9

1.08

0.04

ND

Prometryn

95.3

6.61

0.21

ND

Terbutryn

92.8

7.42

0.18

ND

Di-n-butyl phthalate

105.4

1.78

0.06

ND

Bromacil

108.5

2.05

0.13

ND

Malathion

103.4

2.04

0.10

ND

Cyanazine

104.1

1.57

0.10

ND

Metolachlor

108.3

1.48

0.04

ND

Chlorpyrifos

101.6

4.05

0.08

ND

Thiobencarb

102.2

1.90

0.02

ND

Aldrin

96.5

7.04

0.09

ND

Triademefon

107.7

1.80

0.05

ND

Dacthal

104.3

1.73

0.04

ND

MGK-264-A

104.2

1.87

0.06

ND

Diphenamid

108.5

1.51

0.03

ND

MGK-264-B

104.2

1.87

0.06

ND

Merphos

110.2

2.08

0.61

ND

Heptachlor epoxide B

104.8

2.81

0.07

ND

Heptachlor epoxide A

102.1

4.64

1.07

0.07

Fluoranthene

101.6

4.42

0.04

ND

g-Chlordane

106.8

1.59

0.06

ND

Stirofos

113.2

5.49

0.11

ND

Disulfoton sulfone

113.9

5.80

0.10

ND

Butaclor

109.4

4.64

0.09

ND

a-Chlordane

106.2

1.58

0.06

ND

Endosulfan I

113.1

2.93

0.11

ND

Fenamiphos

113.2

5.15

0.12

ND

Pyrene-d10

105.5

1.59

-

ND

Pyrene

107.1

1.22

0.07

ND

Napropamide

119.8

5.79

0.10

ND

trans-Nonachlor

99.2

2.06

0.07

ND

4,4'-DDE

105.7

1.65

0.07

ND

Dieldrin

108.2

2.05

0.07

ND

Tricyclazole

97.0

5.88

0.12

ND

Terphenyl-d14

126.8

7.93

-

6.35

Carboxin

78.6

8.09

0.17

ND

Endrin

104.1

1.46

0.06

ND

Chlorobenzilate

108.9

5.29

0.10

ND

100) Endosulfan II

111.4

3.48

0.13

ND

4,4'-DDD

108.4

1.67

0.05

ND

Endrin Aldehyde

106.0

5.13

0.16

ND

Butyl benzyl phthalate

110.1

3.54

0.05

ND

Norflurazon

106.9

5.95

0.08

ND

4,4-DDT

108.4

1.67

0.05

ND

Endosulfan Sulfate

112.8

4.00

0.09

ND

Bis(2-ethylhexyl)adipate

103.6

2.16

0.14

ND

Hexazinone

111.4

4.51

0.07

ND

Triphenylphosphate

108.9

3.92

-

ND

Analyte

Average Recovery (%) n=6

RSD (%) n=6

MDL (μg/L)

n=7

Blank (μg/L)

n=6

Endrin Ketone

117.6

3.92

0.09

ND

Methoxychlor

100.8

1.63

0.17

ND

Benz(a)anthracene

95.0

3.12

0.05

ND

Chrysene

102.6

2.11

0.04

ND

Bis(2-ethylhexyl)phthalate

104.2

2.06

0.11

ND

Fenarimol

111.0

6.23

0.11

ND

cis-Permethrin

99.5

2.27

0.13

ND

trans-Permethrin

102.3

1.91

0.12

ND

Di-n-octyl phthalate

106.4

2.05

0.07

0.17

Benzo(b)fluoranthene

100.5

2.36

0.07

ND

Benzo(k)fluoranthene

101.0

3.34

0.04

ND

Benzo(a)pyrene

83.5

6.57

0.11

ND

Fluridone

103.1

4.64

0.09

ND

Perylene-d12

79.1

8.55

-

ND

Indeno(1,2,3-cd)pyrene

86.7

5.29

0.16

ND

Dibenz(ah)anthracene

77.9

5.72

0.05

ND

Benzo(ghi)perylene

93.4

5.20

0.11

ND

 

Conclusion


With the exception of hexachlorocyclopentadiene, carboxin, atraton and prometon, all analytes were recovered within 70–130 % of the known value, in compliance with Method 525.2 criterion for spike recoveries. The average spike (including the problem compounds) recovered at 100.9 %.

Hexachlorocyclopentadiene’s low recovery (27.6 %) can be attributed to the compound’s sensitivity to thermal and photochemical degradation, as well as its propensity to react with acetone. The recovery of carboxin (78.6 %) can be attributed to its significant instability in water. The low recoveries for atraton and prometon of (25.3 % and 37.6 %
respectively) likely stem from inefficient extraction from the water at pH 2, which causes ionization in solution under acidic conditions.1

The relative standard deviation for all compounds ranged from 0.88–28.6 %, below the method’s RSD criteria of <30 %. The NEW Atlantic® ReadyDisk HC-C18 provided excellent analyte accuracy and precision in an easy-to-use, plug-n-play format.


References

  1. United States Environmental Protection Agency, Method 525.2, Revision 2.0: Determination of Organic Compounds in Drinking Water by Liquid-Solid Extraction and Capillary Cartridge Gas Chromatography/Mass Spectrometry.


Ordering Information

Part Number

Description

Quantity

47-6006

Atlantic® ReadyDisk HC-C18

Pk/24

40-705-HT

DryDisk® 65 mm

Pk/50

 

Literature number: AN899

Published: Dec 6, 2025 9:30:00 PM

Related literature